Hawaii legislative agenda & upcoming votes Hawaii session calendar
Summary
Prohibits covered entities in the State from entering into contracts with drug manufacturers that limit the covered entities' use of contract pharmacies. Voids contract provisions for certain drugs if the provisions are based on the maximum allowable cost payment model. Authorizes the attorney general to bring a civil action for violations.
- HB 562 is a bill in the Hawaii House, 2026 session, introduced January 17, 2025.
- Sponsored by CHUN, AMATO, BELATTI, GRANDINETTI, IWAMOTO, LOWEN, MARTEN, MIYAKE, PERRUSO, POEPOE, TAKAYAMA, TAKENOUCHI, TAM, and TODD.
- Current status: introduced.
- Most recent action (December 8, 2025): Carried over to 2026 Regular Session.
- Subjects: 340B Drug Discount Program, Consumer Protection, Maximum Allowable Cost.
-
State Representative, District 35
Democratic -
State Representative, District 11
Democratic -
State Representative, District 26
Democratic -
State Representative, District 20
Democratic -
State Representative, District 25
Democratic -
State Representative, District 7
Democratic
Contact your legislator about this bill
Bill text & documents
Sponsors
Primary: CHUN, AMATO, BELATTI, GRANDINETTI, IWAMOTO, LOWEN, MARTEN, MIYAKE, PERRUSO, POEPOE, TAKAYAMA, TAKENOUCHI, TAM, TODD
History
- Introduced, completed
- Passed House, in progress
- Passed Senate, not reached yet
- Sent to Governor, not reached yet
- Signed into law, not reached yet
- House Pending introduction.
- House Referred to HLT, CPC, JHA, referral sheet 2
- House Introduced and Pass First Reading. Milestone
- Legislature Carried over to 2026 Regular Session. Latest